Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases in serum estradiol after using vaginal estradiol tablets for 12 weeks, according to a ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

A session at the recent Nurse Practitioners in Women's Health annual conference focused on vulvovaginal changes that occur during menopause, the effects of atrophic vaginitis on postmenopausal women, ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...

The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement ...

The choice of the specific type and category of hormone therapy will depend on a woman’s individual symptoms, medical history ...

Researchers saw no link between vaginal estrogen therapy and recurrent strokes, despite concerns that the hormone is systemically absorbed. In a case-control study of female stroke survivors across ...

A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...